Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating ACT500 in healthy adult participants, reporting safety, tolerability, and pharmacokinetics in the context of non-alcoholic steatohepati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• ACT500

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Non-alcoholic Steatohepatitis | Phase 1 | Status: COMPLETED